Chelsea holding her father's hand at a psychiatric hospital, days before he passed away with Alzheimer's disease at the age of 61 In an interview with UCI undergraduate students, Chelsea Cox, Associate Director of Eduction for UCI MIND, shares her personal journey with Alzheimer's disease, her perspective on care and research, and how people - young and old - can get involved in the cause. "...No one should have to spend their final days that way. This experience is what motivated me to get involved in Alzheimer’s research and education. So that hopefully, one day, other people don’t have to…
Read More
Tune in this Friday, March 1 @ 9AM for the next episode of our monthly Facebook LIVE series, "What causes memory problems in older adults?" This month, we're joined by Ahmad Sajjadi, MD, PhD, Assistant Professor of Neurology in the UCI School of Medicine. Dr. Sajjadi received his medical degree from Tehran University of Medical Sciences in Iran and his PhD from the University of Cambridge in the UK. Dr. Sajjadi is a behavioral neurologist who sees patients with memory concerns and also conducts research on Alzheimer’s disease and atypical forms of dementia. To attend live and ask questions, login…
Read More
Maria Shriver discusses the importance of clinical trial participation and the EXERT Study of exercise in adults (65-89) with memory concerns. To learn more about this study, led by Carl Cotman, PhD at UCI MIND, call (949) 824-0008 or email research@mind.uci.edu.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
Read More
Robert K. Chin/Alamy On February 11, the FDA issued a statement and 12 warning letters related to an aggressive change in the agency’s regulation of dietary supplements. The statement was outlined in the New York Times. The main objective of the new approach is enhanced protection of consumers from mislabeled and unproven claims about treatment of disease. At the core of the problem are a number of companies that specifically target people with Alzheimer’s disease and people who are concerned about developing Alzheimer’s disease. A list of the companies receiving warning letters, as well as links to the letters, can…
Read More
Facebook Live Series - ASK THE DOC: Alzheimer's Research Today! This monthly series features short talks and Q&A with experts from the University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), 1 of 32 congressionally designated Alzheimer’s Disease Research Centers in the nation. Join UCI MIND on Facebook (@UCIrvineMIND) the first Friday of every month from 9:00-9:30 AM PST to learn about advances in research to improve Alzheimer’s disease diagnosis, treatment, and prevention. Episode 1: "Can poor sleep cause Alzheimer's?" Bryce Mander, PhD, is Assistant Professor of Psychiatry & Human Behavior at UCI. He received his…
Read More
Leslie Thompson, PhD, Chancellor's Professor of Psychiatry & Human Behavior, Neurobiology & Behavior (Photo credit: Steve Zylius/UCI) UCI News, January 30, 2019 - "Leslie Thompson of the Sue & Bill Gross Stem Cell Research Center and UCI MIND has been awarded $6 million by the California Institute for Regenerative Medicine to continue her CIRM-supported efforts to create stem cell treatments for Huntington’s disease. The funding will allow the Thompson lab to conduct the late-stage testing needed to apply to the U.S. Food and Drug Administration for permission to start a clinical trial in people. The therapy involves transplanting stem cells…
Read More
Eric Doran, Manager of UCI MIND’s Down Syndrome Program, has partnered with his longtime friend and playwright, Steven Oberman, to tell the true story of Dr. John Langdon Down, the man who first described Down syndrome. We interviewed Mr. Doran to learn more about the vision behind this new play, Blurred at the Edges, set to run in March of 2019 at the Diversionary Theatre in San Diego. Eric Doran, MS What is the vision behind Blurred at the Edges? Down syndrome is named after Dr. John Langdon Down, a British physician who first described the condition in 1866. Most…
Read More
